Wall Street Numbers logo
Wall Street Numbers logo
Wall Street Numbers
Arcutis Biotherapeutics, Inc. company logo
Arcutis Biotherapeutics, Inc. logo

Arcutis Biotherapeutics, Inc. (ARQT)

Profile

Company profile for Arcutis Biotherapeutics, Inc. (ARQT)
MetricValue
Full NameArcutis Biotherapeutics, Inc.
TickerNASDAQ: ARQT
ExchangeNASDAQ
SectorHealthcare
IndustryBiotechnology
CountryUnited States
IPO
IndexesNot included
Websitearcutis.com
Employees342

Key Metrics

Arcutis Biotherapeutics, Inc. Key Details
MetricDateValue
Price$29.58
Price, 1D Change+1.23%
Market Cap$4B
-
PE Ratio-
Beta1.14
Revenue$197M
Revenue, 1Y Change+229.74%
EPS-$1.16
EPS, 1Y Change+69.39%

Chart

Add series to chart(max: 6)
Series
SUGGESTED SERIES
Arcutis Biotherapeutics, Inc. chart

Events

Arcutis Biotherapeutics, Inc. Events
MetricDateValue
Next Earnings
Last Qtr. Earnings
Last Ann. Earnings
Last Ex-DividendN/AN/A
Next Ex-DividendN/AN/A
Last SplitN/AN/A
Next SplitN/AN/A
Last Ticker ChangeN/AN/A
Next Ticker ChangeN/AN/A

🔒 Log In To Unlock Full Data

Estimates

ARQT Estimates
MetricDateValue
EPS-$1.16
EPS Estimate-$0.15
EPS Est. Change+87.04%
Revenue$196.54M
Revenue Estimate$357.45M
Revenue Est. Change+81.87%
Current Price$29.58
Price Target-$30.50
Price Tgt. Change-+3.11%

🔒 Log In To Unlock Full Data

EPS

ARQT EPS reported versus estimate values
YearEstimateReportedSurprise / Exp.
-$3.91-$3.78+3.26%
-$1.34-$1.16+13.60%
-$0.15N/A+87.04%
$0.45N/A+138.87%
ARQT EPS reported versus estimate values chart

Revenue

ARQT revenue reported versus estimate values chart
YearEstimateReportedSurprise / Exp.
$57.55M$59.61M+3.57%
$185.49M$196.54M+5.96%
$357.45MN/A+81.87%
$467.32MN/A+137.77%
ARQT revenue reported versus estimate values chart

🔒 Log In To Unlock Full Data

Performance

ARQT Performance
MetricDateValue
Price, 1Y+87.69%
Price, 3Y+97.07%
Market Cap, 1Y+95.09%
Market Cap, 3Y+295.49%
Revenue, 1Y+229.74%
Revenue, 3Y+100.00%
EPS, 1Y+69.39%
EPS, 3Y+72.28%

🔒 Log In To Unlock Full Data

Technical Indicators

ARQT Technical Indicators
MetricDateValue
Current Price$29.58
SMA 200$18.67
SMA 200 vs Price-36.90%
SMA 50$27.74
SMA 50 vs Price-6.22%
Beta1.14
ATR$1.25
14-Day RSI55.34
10-Day Volatility38.33%
1-Year Volatility65.64%

Dividends

ARQT Dividends
MetricDateValue
N/A-
UpcomingN/AN/A
-
-
Dividends Paid$0.00
Payout Ratio0.00%

🔒 Log In To Unlock Full Data

Income & Profitability

ARQT Income & Profitability
MetricDateValue
Revenue$196.54M
EPS-$1.16
Gross Profit$177.41M
Gross Margin90.27%
Operating Profit-$128.40M
Operating Margin-65.33%
Net Income-$140.04M
Net Margin-71.25%
EBITDA-$109.63M

🔒 Log In To Unlock Full Data

Financial Health

ARQT Financial Health
MetricDateValue
Debt To Equity0.70
Current Ratio4.15
Quick Ratio3.97
-
F-Score4
Altman Z-Score7.24

Valuations

ARQT Valuations
MetricDateValue
PE Ratio-
PS Ratio11.40
PB Ratio22.92
EV/EBITDA-105.74
Enterprise ValueN/A-

Balance Sheet

ARQT Balance Sheet
MetricDateValue
Book Value$157.54M
Cash & Equivalents$71.34M
Total Assets$348.89M
Current Assets$335.82M
Total Liabilities$191.35M
Current Liabilities$81.01M
Total Debt$110.59M
Short Term Debt$820.00K
Accounts Payable$14.22M

Expenses

ARQT Expenses
MetricDateValue
Total Expenses$324.94M
Operating Expenses$305.81M
Cost Of Goods Sold$19.13M
SG&A$229.39M
D&A$2.60M
Interest Expense$0.00
Income Tax$647.00K

Cash Flow

ARQT Cash Flow
MetricDateValue
CFO-$112.16M
CFI$28.82M
CFF$66.20M
Capex$5.14M
Free Cash Flow-$117.30M

Recent analyst updates

ARQT Recent analyst updates
MetricDateValue
Mizuho→
Goldman Sachs→
Needham→
Needham→
Goldman Sachs
Needham→
Needham→
Needham→
HC Wainwright & Co.→
Guggenheim→

Analyst sentiment

Sentiment over the past month
ARQT analyst sentiment distribution chart

Institutional ownership

Largest institutional holders by ownership percentage
ARQT institutional ownership distribution chart

Screeners with ARQT

Data Sources & References

  1. ARQT Official Website www.arcutis.com
  2. Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1787306/000178730625000144/0001787306-25-000144-index.htm
  3. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1787306/000178730625000029/0001787306-25-000029-index.htm
  4. ARQT Profile on Yahoo Finance finance.yahoo.com/quote/ARQT
  5. ARQT Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/arqt

FAQ

  • What is the ticker symbol for Arcutis Biotherapeutics, Inc.?

    The ticker symbol for Arcutis Biotherapeutics, Inc. is NASDAQ:ARQT

  • Does Arcutis Biotherapeutics, Inc. pay dividends?

    No, Arcutis Biotherapeutics, Inc. does not pay dividends

  • What sector is Arcutis Biotherapeutics, Inc. in?

    Arcutis Biotherapeutics, Inc. is in the Healthcare sector

  • What industry is Arcutis Biotherapeutics, Inc. in?

    Arcutis Biotherapeutics, Inc. is in the Biotechnology industry

  • What country is Arcutis Biotherapeutics, Inc. based in?

    Arcutis Biotherapeutics, Inc. is headquartered in United States

  • When did Arcutis Biotherapeutics, Inc. go public?

    Arcutis Biotherapeutics, Inc. initial public offering (IPO) was on January 31, 2020

  • Is Arcutis Biotherapeutics, Inc. in the S&P 500?

    No, Arcutis Biotherapeutics, Inc. is not included in the S&P 500 index

  • Is Arcutis Biotherapeutics, Inc. in the NASDAQ 100?

    No, Arcutis Biotherapeutics, Inc. is not included in the NASDAQ 100 index

  • Is Arcutis Biotherapeutics, Inc. in the Dow Jones?

    No, Arcutis Biotherapeutics, Inc. is not included in the Dow Jones index

  • When was Arcutis Biotherapeutics, Inc. last earnings report?

    Arcutis Biotherapeutics, Inc.'s most recent earnings report was on October 28, 2025

  • When does Arcutis Biotherapeutics, Inc. report earnings?

    The next expected earnings date for Arcutis Biotherapeutics, Inc. is February 24, 2026